AR012872A1 - Uso del mometanosulfonato del acido (e)-alfa-[2-n-butil-1-[(carboxifenil)metil]-1-h-imidazol-5- il]metilen-2-tiofenpropionico para la fabricacion de un medicamento ycomposicion farmaceutica que lo comprende para tratar hipertension sistolica aislada. - Google Patents
Uso del mometanosulfonato del acido (e)-alfa-[2-n-butil-1-[(carboxifenil)metil]-1-h-imidazol-5- il]metilen-2-tiofenpropionico para la fabricacion de un medicamento ycomposicion farmaceutica que lo comprende para tratar hipertension sistolica aislada.Info
- Publication number
- AR012872A1 AR012872A1 ARP980102464A ARP980102464A AR012872A1 AR 012872 A1 AR012872 A1 AR 012872A1 AR P980102464 A ARP980102464 A AR P980102464A AR P980102464 A ARP980102464 A AR P980102464A AR 012872 A1 AR012872 A1 AR 012872A1
- Authority
- AR
- Argentina
- Prior art keywords
- methylene
- alpha
- butyl
- methyl
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La utilizacion de ácido (E)-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1-H- imidazol-5-il]metilen-2-tiofenpropionico (eprosartán) en la fabricacion de unmedicamento que se destina para el tratamiento de hipertension sistolica aislada.Una composicion farmacéutica para utilizacion en el tratamiento dehipertension sistolica aislada que comprende ácido (E)-alfa-[2-n-butil-1-[(4- carboxifenil)metil]-1-H-imidazol-5-il]metilen-2-tiofdenpropionico (eprosartán yun vehículo farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4780097P | 1997-05-27 | 1997-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012872A1 true AR012872A1 (es) | 2000-11-22 |
Family
ID=21951046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102464A AR012872A1 (es) | 1997-05-27 | 1998-05-27 | Uso del mometanosulfonato del acido (e)-alfa-[2-n-butil-1-[(carboxifenil)metil]-1-h-imidazol-5- il]metilen-2-tiofenpropionico para la fabricacion de un medicamento ycomposicion farmaceutica que lo comprende para tratar hipertension sistolica aislada. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20020040045A1 (es) |
| EP (1) | EP1003506B1 (es) |
| JP (1) | JP2002500673A (es) |
| KR (1) | KR20010013014A (es) |
| CN (1) | CN1257427A (es) |
| AR (1) | AR012872A1 (es) |
| AT (1) | ATE307580T1 (es) |
| AU (1) | AU740646B2 (es) |
| BR (1) | BR9809611A (es) |
| CA (1) | CA2288722C (es) |
| CZ (1) | CZ298390B6 (es) |
| DE (1) | DE69832075T2 (es) |
| ES (1) | ES2251083T3 (es) |
| HU (1) | HUP0003249A3 (es) |
| IL (1) | IL132154A (es) |
| MX (1) | MXPA99010970A (es) |
| NO (1) | NO326141B1 (es) |
| NZ (1) | NZ337888A (es) |
| PL (1) | PL191971B1 (es) |
| SA (1) | SA98190174B1 (es) |
| TR (1) | TR199902914T2 (es) |
| TW (1) | TW579296B (es) |
| WO (1) | WO1998053816A1 (es) |
| ZA (1) | ZA984421B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006076097A2 (en) * | 2004-12-07 | 2006-07-20 | Nektar Therapeutics | Stable non-crystalline formulation comprising losartan |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US544080A (en) * | 1895-08-06 | Centrifugal filtering-machine | ||
| US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| US5418250A (en) * | 1989-06-14 | 1995-05-23 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| JPH05199342A (ja) * | 1991-05-20 | 1993-08-06 | Xerox Corp | 無声の手書きによる携帯式通信装置および方法 |
-
1998
- 1998-05-25 ZA ZA984421A patent/ZA984421B/xx unknown
- 1998-05-27 NZ NZ337888A patent/NZ337888A/en unknown
- 1998-05-27 PL PL336886A patent/PL191971B1/pl not_active IP Right Cessation
- 1998-05-27 DE DE69832075T patent/DE69832075T2/de not_active Expired - Lifetime
- 1998-05-27 AT AT98923815T patent/ATE307580T1/de not_active IP Right Cessation
- 1998-05-27 CA CA002288722A patent/CA2288722C/en not_active Expired - Fee Related
- 1998-05-27 HU HU0003249A patent/HUP0003249A3/hu unknown
- 1998-05-27 IL IL13215498A patent/IL132154A/en not_active IP Right Cessation
- 1998-05-27 KR KR1019997010988A patent/KR20010013014A/ko not_active Application Discontinuation
- 1998-05-27 CN CN98805305A patent/CN1257427A/zh active Pending
- 1998-05-27 BR BR9809611-7A patent/BR9809611A/pt not_active Application Discontinuation
- 1998-05-27 AU AU76017/98A patent/AU740646B2/en not_active Ceased
- 1998-05-27 AR ARP980102464A patent/AR012872A1/es not_active Application Discontinuation
- 1998-05-27 TR TR1999/02914T patent/TR199902914T2/xx unknown
- 1998-05-27 ES ES98923815T patent/ES2251083T3/es not_active Expired - Lifetime
- 1998-05-27 TW TW087108204A patent/TW579296B/zh not_active IP Right Cessation
- 1998-05-27 MX MXPA99010970A patent/MXPA99010970A/es not_active IP Right Cessation
- 1998-05-27 EP EP98923815A patent/EP1003506B1/en not_active Expired - Lifetime
- 1998-05-27 CZ CZ0420099A patent/CZ298390B6/cs not_active IP Right Cessation
- 1998-05-27 WO PCT/US1998/010794 patent/WO1998053816A1/en active IP Right Grant
- 1998-05-27 JP JP50086599A patent/JP2002500673A/ja active Pending
- 1998-06-17 SA SA98190174A patent/SA98190174B1/ar unknown
-
1999
- 1999-11-26 NO NO19995797A patent/NO326141B1/no not_active IP Right Cessation
-
2001
- 2001-10-24 US US09/999,808 patent/US20020040045A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ZA984421B (en) | 1998-11-27 |
| EP1003506B1 (en) | 2005-10-26 |
| AU740646B2 (en) | 2001-11-08 |
| NO326141B1 (no) | 2008-10-06 |
| SA98190174B1 (ar) | 2006-05-13 |
| PL191971B1 (pl) | 2006-07-31 |
| HUP0003249A3 (en) | 2002-02-28 |
| NO995797D0 (no) | 1999-11-26 |
| DE69832075D1 (de) | 2005-12-01 |
| NZ337888A (en) | 2001-04-27 |
| MXPA99010970A (es) | 2005-07-25 |
| NO995797L (no) | 1999-11-26 |
| CZ298390B6 (cs) | 2007-09-19 |
| IL132154A (en) | 2002-12-01 |
| CA2288722A1 (en) | 1998-12-03 |
| CN1257427A (zh) | 2000-06-21 |
| JP2002500673A (ja) | 2002-01-08 |
| US20020040045A1 (en) | 2002-04-04 |
| IL132154A0 (en) | 2001-03-19 |
| BR9809611A (pt) | 2000-07-04 |
| PL336886A1 (en) | 2000-07-17 |
| CA2288722C (en) | 2007-04-24 |
| CZ420099A3 (cs) | 2000-09-13 |
| AU7601798A (en) | 1998-12-30 |
| TR199902914T2 (xx) | 2000-06-21 |
| ATE307580T1 (de) | 2005-11-15 |
| EP1003506A1 (en) | 2000-05-31 |
| EP1003506A4 (en) | 2000-11-29 |
| ES2251083T3 (es) | 2006-04-16 |
| WO1998053816A1 (en) | 1998-12-03 |
| KR20010013014A (ko) | 2001-02-26 |
| DE69832075T2 (de) | 2006-07-13 |
| TW579296B (en) | 2004-03-11 |
| HUP0003249A2 (hu) | 2002-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0000299A1 (hu) | Késleltetett hatóanyag-leadású gyógyszerkészítmények | |
| BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
| AR002030A1 (es) | Composiciones farmaceuticas para administracion a la piel o a las mucosas, y uso de una combinacion de aciclovir e hidrocortisona para la elaboracion de medicamentos | |
| AR013506A1 (es) | Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida | |
| UA88270C2 (ru) | Фармацевтический препарат и его применение для профилактики удара, диабета | |
| ATE309798T1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
| AR035500A1 (es) | Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina. | |
| AR033548A1 (es) | Composicion farmaceutica que comprende un inhibidor de lipasa, un procedimiento para su preparacion, equipo transportable a modo de ''kit'', el uso de dicha composicion en la fabricacion de medicamentos, un inhibidor de lipasa y un secuestrante de acidos biliares | |
| BR9712523A (pt) | Novos derivados de pirazol heterociclilmetil-substituìdos | |
| AR082579A2 (es) | Una composicion farmaceutica espontaneamente dispersable para la administracion oral, uso para la preparacion de un medicamento para el tratamiento del cancer, metodo para incrementar los niveles de biodisponibilidad o reducir su variabilidad | |
| EP1249238A8 (en) | Topical pharmaceutical composition comprising bethanechol | |
| ES2190692B1 (es) | Formulacion farmaceutica de amoxicilina y clavulanato de potasio. | |
| IT1255460B (it) | Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive | |
| AR008886A1 (es) | Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea | |
| HUP0400553A2 (hu) | Gyógyászati készítmények | |
| CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
| CR6834A (es) | Complejos y composiciones de medicamentos macromoleculares que contienen lo mismo | |
| AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
| BR0007452A (pt) | Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação | |
| ES2174533T3 (es) | Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas. | |
| SE9603480L (sv) | Beredningsform för svårlösliga läkemedel | |
| ATE311904T1 (de) | Halbfester verabreichungsträger und arzneimittel | |
| WO2003018535A3 (en) | Novel aminobenzoephenones | |
| AR012872A1 (es) | Uso del mometanosulfonato del acido (e)-alfa-[2-n-butil-1-[(carboxifenil)metil]-1-h-imidazol-5- il]metilen-2-tiofenpropionico para la fabricacion de un medicamento ycomposicion farmaceutica que lo comprende para tratar hipertension sistolica aislada. | |
| AR012638A1 (es) | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |